EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Molecular Mechanisms of Diffuse Large B-Cell Lymphoma and the Complexities of Tumor Development

Wael I Alzahrani iD

Saudi Medical Journal · 2026

DOI: 10.15537/1658-3175.8802 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Saudi Medical Journal, 2026. Verfasst von Wael I Alzahrani. Beteiligte Einrichtung: Department of Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, Al Jouf, Saudi Arabia. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B-cell lymphoma (DLBCL), the most prevalent aggressive non-Hodgkin lymphoma, exhibits substantial molecular heterogeneity and arises from germinal center or post-germinal center B cells through recurrent genetic and epigenetic dysregulation of critical signaling pathways. Aberrations involving BCL6, MYC, MYD88, and components of B cell receptor and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κ B) signaling play central roles in lymphomagenesis, treatment resistance, and clinical outcomes. Gene expression profiling has defined major molecular subgroups in DLBCL, including germinal center B cell–like and activated B cell–like tumors, that show distinct pathogenesis and prognosis. High-risk entities, such as double- and triple-hit lymphomas, remain therapeutically challenging despite advances in immunochemotherapy. Recent progress in molecular diagnostics and targeted therapies, including immune checkpoint inhibition, Bruton tyrosine kinase inhibitors, B-cell lymphoma 2 (BCL2) antagonists, and Chimeric antigen receptor-T cells, has expanded precision-based treatment strategies. This review summarizes advances in understanding the molecular mechanisms of DLBCL and emphasizes emerging therapeutic approaches informed by genomic and microenvironmental discoveries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseHumansSignal TransductionProto-Oncogene Proteins c-bcl-6Myeloid Differentiation Factor 88Epigenesis, Genetic

Stichwörter der Autor:innen

Diffuse large B-cell lymphomaEpigenetic regulationGenetic alterationsMolecular pathogenesisTargeted therapy

Substanzen

Proto-Oncogene Proteins c-bcl-6BCL6 protein, humanMyeloid Differentiation Factor 88

Autor:innen und Institutionen

  • Department of Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, Al Jouf, Saudi Arabia.

ORCID-Profile: Wael I Alzahrani

Zitieren

APA

Alzahrani, W. I. (2026). Molecular Mechanisms of Diffuse Large B-Cell Lymphoma and the Complexities of Tumor Development. Saudi Medical Journal. https://doi.org/10.15537/1658-3175.8802

Vancouver

Alzahrani WI. Molecular Mechanisms of Diffuse Large B-Cell Lymphoma and the Complexities of Tumor Development. Saudi Medical Journal. 2026. doi:10.15537/1658-3175.8802

BibTeX
@article{Alzahrani2026,
  author = {Alzahrani, Wael I},
  title = {Molecular Mechanisms of Diffuse Large B-Cell Lymphoma and the Complexities of Tumor Development},
  journal = {Saudi Medical Journal},
  year = {2026},
  doi = {10.15537/1658-3175.8802}
}
Kostenlos starten →